Comprehensive analysis of Kotak Nifty 50 Equal Weight Index Fund - Dir (IDCW) (45335) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Kotak Mahindra Asset Management Company Ltd
The investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved
A comprehensive at-a-glance view of key mutual fund health indicators
Good Returns
High Risk
Low Expense Ratio
Equity Focused
New Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Recent performance momentum
Outperformance vs benchmark
Market exposure level
Fund management costs
Historical performance consistency
Risk-adjusted returns
Fund manager experience
Assets under management
This fund has underperformed its benchmark by 6.75% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| Eternal Ltd | E-Commerce/App based Aggregator | 2.44% |
| Hindustan Unilever Ltd | FMCG | 2.26% |
| Jio Financial Services Ltd | Finance | 2.22% |
| Apollo Hospitals Enterprise Ltd | Healthcare | 2.15% |
| Asian Paints Ltd | Paints/Varnish | 2.15% |
| ICICI Bank Ltd | Banks | 2.13% |
| Jio Financial Services Ltd | Finance | 2.12% |
| Cipla Ltd | Pharmaceuticals | 2.10% |
| UltraTech Cement Ltd | Cement | 2.09% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 2.09% |
Compare against Index Fund category average
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1229.16 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1229.15 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1195.53 | 0.38% | 2.69% | 4.86% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1195.51 | 0.38% | 2.69% | 4.86% |
| HDFC BSE Sensex Index Fund - Direct | ₹790.24 | 3.06% | 10.66% | 7.25% |
| HDFC BSE Sensex Index Fund - Regular | ₹771.61 | 3.04% | 10.61% | 7.17% |
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.